本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

4D Molecular Therapeutics

4.22
-0.1400-3.21%
盤後4.220.00000.00%18:16 EDT
成交量:31.69萬
成交額:135.59萬
市值:1.95億
市盈率:-1.33
高:4.45
開:4.40
低:4.17
收:4.36
資料載入中...

公司資料

公司名字:
4D Molecular Therapeutics
交易所:
NASDAQ
成立時間:
2013
員工人數:
227
公司地址:
5858 Horton Street,Suite 455,Emeryville,California,United States
郵編:
94608
電話:
傳真:
- -
簡介:
4D Molecular Therapeutics, Inc.於2015年3月11日根據特拉華州法律成立。該公司是一家領先的臨床階段生物製藥公司,專註於通過針對特定疾病治療進行優化的專有定製載體釋放基因藥物的全部潛力。

董事

名稱
職位
David Kirn
Director and Chief Executive Officer
John F. Milligan
Executive Chairman of the Board
Charles Theuer
Independent Director
Jacob Chacko
Independent Director
Nancy Miller Rich
Independent Director
Shawn Cline Tomasello
Independent Director
Susannah Gray
Independent Director

股東

名稱
職位
David Kirn
Director and Chief Executive Officer
Fariborz Kamal
President and Chief Operating Officer
John F. Milligan
Executive Chairman of the Board
Noriyuki Kasahara
Chief Scientific Officer
Robert Young Kim
Chief Medical Officer
Scott Bizily
Chief Legal Officer and Corporate Secretary